Instructions for use Flekosteel

How To Use Flekosteel Gel Instructions In Nigeria

Gel for joints and back

Method of administration and dosage

For adults and children over 12 years of age, the drug is applied in a thin layer to the skin in the area of inflammation 2-3 times a day at a dose of 2 g (about 4 cm with the mouth fully open). tube) and lightly rubbed A single dose of the drug - 2 g The maximum daily dose of the drug should not exceed 6 g. Apply in minimum effective dose for minimum short term.

Indication	Contraindications
post-traumatic soft tissue inflammation, eg due to sprains, strains, bruises, injuries; - rheumatic diseases and soft tissue swelling (tendovaginitis, bursitis, periarticular tissue damage, wrist syndrome); - pain in the joints (joints of fingers, knees, etc. ) with osteoarthritis; - back pain in inflammatory and degenerative diseases of the spine (osteoarthritis, sciatica, lumbago, sciatica). The drug is intended for symptomatic therapy, reduces pain and inflammation at the time of use, does not affect the development of the disease.	- hypersensitivity to diclofenac or other components of the drug; - complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose and colonic sinuses, intolerance to salicylates or other NSAIDs (including history); - pregnancy (third trimester); - breastfeeding period; - children's age (up to 12 years); - violation of the integrity of the skin at the place of intended application.

Indication

Contraindications

post-traumatic soft tissue inflammation, eg due to sprains, strains, bruises, injuries; - rheumatic diseases and soft tissue swelling (tendovaginitis, bursitis, periarticular tissue damage, wrist syndrome); - pain in the joints (joints of fingers, knees, etc. ) with osteoarthritis; - back pain in inflammatory and degenerative diseases of the spine (osteoarthritis, sciatica, lumbago, sciatica). The drug is intended for symptomatic therapy, reduces pain and inflammation at the time of use, does not affect the development of the disease.

- hypersensitivity to diclofenac or other components of the drug; - complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose and colonic sinuses, intolerance to salicylates or other NSAIDs (including history); - pregnancy (third trimester); - breastfeeding period; - children's age (up to 12 years); - violation of the integrity of the skin at the place of intended application.